The primary objective of this study is to develop and validate claims-based algorithms to identify intracerebral hemorrhage \>1 cm in diameter, ensuring differentiation from amyloid-related imaging abnormality-microhemorrhage and hemosiderin deposit (ARIA-H; microhemorrhage, superficial siderosis) in participants with Alzheimer's disease (AD) using claims data in the United States (US) with linkage to electronic health records (EHRs), and to estimate the positive predictive values (PPVs) of the algorithms. The secondary objective of the study is to validate claims-based algorithms to identify new-onset seizures in participants with AD using US claims data with linkage to EHRs and to estimate the PPVs of the algorithms.
As this is a Retrospective Database Study, the Study Start Date for this study references the date at which the first set of data will become available.
Study Type
OBSERVATIONAL
Enrollment
600
This is a non-interventional study.
Eisai Site #1
Nutley, New Jersey, United States
Positive Predictive Value (PPV) of algorithms to identify intracerebral hemorrhage >1 cm in diameter
Time frame: Up to 9.5 years
PPV of algorithms to identify new-onset seizure
Time frame: Up to 9.5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.